Cirqle Biomedical Holding ApS: Financial statements 2020
CVR: 39849585
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Cirqle Biomedical Holding ApS (CVR 39849585) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -7,329 and a net result of DKK -10,281. Equity in the 2020 report amounted to DKK 37,221. The solvency ratio was 7.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -7,329
- Profit/Loss
- DKK -10,281
- Equity
- DKK 37,221
- Total Assets
- DKK 504,338
- Employees
- 1
Official annual report
How creditworthy is Cirqle Biomedical Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
On August 17, 2020, the company changed its name from Circle Biomedical Holding IVS to Circle Biomedical Holding ApS.
Cirqle Biomedical Holding ApS has published its interim report for the period September 10, 2018 to December 31, 2019.
About Cirqle Biomedical Holding ApS
Cirqle Biomedical Holding ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Circle Biomedical Holding ApS and Circle Biomedical Holding IVS. The management consists of Frederik Petursson Madsen and Thomas Crouzier. The company is owned by FREDERIK MADSEN HOLDING ApS and Seatoo Holding ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -60,937 and a net result of DKK -137,510 compared with DKK 12,948,727 the year before. Equity in the 2025 report amounted to DKK 577,835.